Stem Cell Trial: iPSCs for Repairing Airway Damage in COPD
The study will test whether induced pluripotent stem cells can help repair airway damage in people with COPD.
Trials
Stem Cell Trial: BlueRock Launches Study of iPSC-Derived Photoreceptor Cell Therapy for Inherited Retinal Diseases
The trial will test whether lab-grown photoreceptor cells can be safely transplanted to help people with inherited vision loss.
Stem Cell and Spinal Stimulation Trial for Chronic Spinal Cord Injury
The study will test whether combining umbilical cord stem cells and spinal cord stimulation can safely help people with chronic spinal cord injury.
Stem Cell Trial: Umbilical Cord MSCs to Prevent Lung Disease in Preterm Infants
Researchers will test if umbilical cord stem cell infusions can safely reduce lung disease in extremely premature infants.
New Trial: iPSC-Derived Exosome Therapy for Moyamoya Disease
Researchers are testing whether exosomes from stem cells can enhance blood vessel repair for Moyamoya patients after surgery.
New Trial: Umbilical Cord Mesenchymal Stem Cells for Lupus
The trial will investigate whether umbilical cord stem cell therapy can calm the autoimmune condition.
BlueRock Therapeutics Begins Phase 1/2a Trial of Stem Cell Therapy OpCT-001 for Retinal Diseases
The Bayer owned company just starting dosing patients with OpCT-001, an iPSC-derived cell therapy aiming to restore vision in inherited retinal diseases.
Longeveron Gains FDA Approval to Begin Phase 2 Stem Cell Trial for Children with Heart Disease
Longeveron will evaluate if it's stem cell candidate, laromestrocel, could target pediatric dilated cardiomyopathy
NextCell Pharma Completes Patient Dosing in Pediatric Diabetes Stem Cell Study
The company has concluded dosing in its largest pediatric diabetes trial, evaluating ProTrans therapy's safety and insulin-preserving potential
Vertex Reports Promising Results from Stem Cell Trial for Type 1 Diabetes
Vertex recently presented encouraging Phase 1/2 results for zimislecel, a stem cell-derived therapy showing sustained insulin production in type 1 diabetes patients.
NurExone reports enhanced scalability and clinical readiness for upcoming exosome-based clinical trials for neurological conditions
The Israeli regenerative medicine company is moving one step closer to clinical trials for serious neurological indications such as TBI, spinal cord injury, etc.
BrainStorm’s ALS stem cell treatment reports 90% survival over 5 years in expanded access program
BrainStorm's NurOwn, its ALS candidate stem cell therapy, has shown significantly higher five-year survival rates compared to expectations in a small 10 participant program.
BioRestorative reports Good Preliminary Data for FDA-Fast-Tracked Stem Cell Therapy for Disc Disease
BioRestorative's early Phase 2 trial results show notable improvements in function and pain for chronic lumbar disc disease patients, moving one step closer to a BLA.
UniXell Biotechnology doses first Parkinson’s patient with iPSCs, reports improvements
The Chinese biotech company reports that the patient showed notable improvements in sleep quality and motor function, with no serious adverse events.
L2 Bio looking for Principal Investigators for its Phase 2B adipose stem cell trial for Crohn’s Disease
The FDA has recently approved them for what appears to be an expanded adipose MSC trial, looking for GI experienced physicians.
First patient dosed in Idopathic Pulmonary Fibrosis peptide Phase 2 from Rein Therapeutics
The Phase 2 trial RCT will evaluate adverse event and efficacy endpoints.
New trial: Umbilical-derived stem cells for knee cartilage
This small German biotech company is joining the knee OA stem cell race.
Stem cell-based alternative to in vitro maturation reports double the pregnancy rate
The company uses iPSCs to create a replica environment for maturing eggs ex vivo, and the data looks promising as they roll into Phase 3.
Organ donor? That may include using your stem cells: first successful transplant using deceased donor in blood Cancer clinical trial
It's interesting to consider, much like with umbilical cords, how often are we incinerating life-saving stem cells?
Parkinson’s stem cell trial launches: Aspen Neuroscience doses first patient with iPSCs
A new milestone for iPSC therapy in the USA, this is one to watch.
FDA approves IV adipose stem cell trial for Crohn’s disease, a Phase 2b from L2 Bio
What appears to be a small stem cell banking company is working on expanded adipose stem cell therapy for various autoimmune conditions.
New Study: Extracellular Vesicles in Fibrin Gel for Cartilage Repair (Italy)
The Italian researchers will do a 51 person trial with MSC-derived EVs in PRP-derived fibrin gels.
New Study: Intrathecal Umbilical Stem Cells + Transcutaneous Stimulation for Spinal Cord Injury
The neurorehabilitation hospital in Spain will investigate if allogeneic umbilical-derived stem cell therapy can help enhance recovery.
Hematopoietic Stem Cell-Directed Gene Insertion Therapy Gets IND Clearance
With FDA clearance secured, Ensoma prepares to launch its Phase 1/2 clinical trial to establish safety, efficacy, and dosing.
Safety and Efficacy of Epicardial Implantation of Collagen Membranes with Allogeneic Adipose-Derived Stem Cells (Cardiomesh)
This study will evaluate if the VB-C01 cellularised patch, a collagen membrane seeded with allogeneic adipose-derived stem cells, is safe and effective for surgical epicardial implantation in patients undergoing coronary artery bypass grafting (CABG) who are at high risk of…